Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 36, Issue 1, Pages 44-50
Publisher
Springer Nature
Online
2014-12-15
DOI
10.1038/aps.2014.116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction
- (2014) Xijun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice
- (2014) F.A.R. Lívero et al. CHEMICO-BIOLOGICAL INTERACTIONS
- FXR is a molecular target for the effects of vertical sleeve gastrectomy
- (2014) Karen K. Ryan et al. NATURE
- Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
- (2013) Weibin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
- (2013) Zhuofeng Lin et al. Cell Metabolism
- Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice
- (2013) Yan Lu et al. GUT
- Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis
- (2013) Jiesi Xu et al. HEPATOLOGY
- FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
- (2013) Elena Maneschi et al. JOURNAL OF ENDOCRINOLOGY
- Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
- (2013) Xuelian Xiong et al. JOURNAL OF HEPATOLOGY
- Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
- (2013) S. Caron et al. MOLECULAR AND CELLULAR BIOLOGY
- Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2013) Yongjie Ma et al. PHARMACEUTICAL RESEARCH
- Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese
- (2012) Yun Huang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nuclear Receptors Reverse McGarry's Vicious Cycle to Insulin Resistance
- (2012) David D. Moore Cell Metabolism
- Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21
- (2012) Holly A. Cyphert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- Diurnal Regulation of MTP and Plasma Triglyceride by CLOCK Is Mediated by SHP
- (2010) Xiaoyue Pan et al. Cell Metabolism
- Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study
- (2010) Elizabeth K. Speliotes et al. HEPATOLOGY
- The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways
- (2010) Mouaadh Abdelkarim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes
- (2010) Linda Vignozzi et al. Journal of Sexual Medicine
- A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
- (2009) Mark J. Evans et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
- (2009) Brenton Flatt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
- (2008) G. Targher et al. DIABETOLOGIA
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Epidemiology of non-alcoholic fatty liver disease in China
- (2008) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search